Peng Wu received the ICBS award

Dr. Wu, Ph.D., Max Planck Institute of Molecular Physiology, Germany, is being recognized for the lab’s research focusing on the synthetic small molecule approaches for perturbing the function of disease-associated RNA-binding proteins. The Wu lab has taken a multi-faceted approach combining both novel screening tools and rational structure- based design for the development of new small-molecule modulators. Recent efforts have produced several different structural classes of RNase L-targeting modulators as potential antiviral agents and inhibitors of the LIN28-let-7 microRNA as potential anticancer
therapeutics.

ICBS2022 Award lecture: “Small molecules targeting RNA-binding proteins and protein–RNA interactions”